Supporting the advance of neurology clinical trials
Around the world, neurology clinical trials are conducting some of the world’s most pressing medical research. From Alzheimer’s disease, Parkinson’s disease, and dementia with Lewy bodies, through to multiple sclerosis and epilepsy, millions of people are living with life-changing conditions that cause significant health impacts.
Often, those impacts stretch far beyond the patient, with emotionally distressed families facing an ever-increasing burden of care that impinges their ability to participate in wider society.
Consider the scale of those affected. More than 55 million people live with dementia* and more than 10 million people live with Parkinson’s disease**. The size of those numbers alone demonstrates exactly why neurology clinical trials are critical in the search for new ways to reduce the frequency and severity of patient symptoms.
Understanding the neurology research landscape
Research into neurological conditions accounts for a significant proportion of the world’s clinical trials. Between 2017 and 2022, only the therapeutic areas of infectious diseases and oncology accounted for a larger percentage of global clinical trials. In that same period, neurology research accounted for one in every 10 clinical trials happening in the world***.
As a result of these efforts, significant progress is being made across a range of neurological conditions. With the numbers of people diagnosed with Alzheimer’s disease expected to double every 20 years, the breakthroughs made by a team of researchers at Kaunas universities in Lithuania could be utterly transformative. Its deep learning method can analyse fMRI images and predict the possible onset of Alzheimer’s disease with an accuracy of more than 99%. Early diagnosis is key to giving patients the best possible chance of benefiting from treatment.
In the United States, neurology researchers at Rush University Medical Center have been able to develop a nasal spray that slows the spread of a protein that is the hallmark of Parkinson’s disease. The spray has been successful during trials on mice. If it can be replicated in humans, it could be one of the biggest advances neurology researchers have ever made.
And in Bristol, England, researchers have been able to learn more about brain processes that help to encode memories, creating new avenues of exploration in the path to find treatments that can combat the most common symptoms of Alzheimer’s disease.
The explosion of machine learning and artificial intelligence is set to accelerate advances across all research fields. Neurological research has already shown its ability to harness AI, and it is expected that progress will significantly quicken as technologies become ever more capable of completing work both faster and more accurately than humans. With neurological conditions being the leading cause of disability and the second leading cause of death worldwide****, these advances cannot come soon enough.
A trusted partner for CROs managing neurology clinical trials
Whether you’re overseeing a trial aiming to displace toxic proteins in the brain or searching for treatments to replace or repair damaged or lost cells, Woodley Trial Solutions has the experience, knowledge, systems, and attention to detail to provide the attentive, long-term support you need to ensure your trial is a success.
We exist entirely to provide the world-leading service that befits today’s most prominent research professionals, going the extra mile for our customers wherever we can. CROs trust us to support their clinical trials for a range of reasons, including:
High-quality equipment
Our extensive product range covers the requirements of even the most challenging neurology clinical trials. CROs appreciate that all our equipment arrives on site fully calibrated and ready to use, enabling the research to proceed at speed.
Dedicated support and assistance
Our team has worked with research professionals for almost 35 years, so we have an in-depth understanding of the pressures and challenges CROs face. We are uniquely equipped to both anticipate unforeseen issues and respond to live situations that require urgent attention.
Unrivalled product knowledge
When you need medical equipment for your neurology clinical trial, it’s imperative to know you are choosing the best possible products. We listen attentively to CROs to understand their needs. From there, we can provide the pros, cons, and full technical details on a range of suitable devices.
Detailed regulatory understanding
Shipping medical equipment around the world is complex and challenging, with different regulatory environments operating in different countries and regions. Our logistics team guides you through this complicated area, enabling you to make an informed choice about the equipment you’ll use.
Innovative data transfer and strong data partnerships
Our detailed product knowledge of connected devices and wearables enables us to ensure your trial collects the data it needs, while our comprehensive agreements with data companies are guaranteeing data security in decentralised clinical trials.
Proven efficiency and reliability
Our logistics operation ensures everything arrives on time, on budget, and ahead of any SIV dates – wherever you’re based. Significant investments in our global stocking and warehousing mean we can guarantee fast deliveries, customs clearance, and distribution through dedicated warehousing hubs.
If you’re a CRO looking for high-quality equipment supplies for your next neurotherapy clinical trial, contact us today. Our dedicated team will be happy to help.
References
* https://dementiastatistics.org/statistics/global-prevalence/
** https://www.parkinson.org/understanding-parkinsons/statistics
*** https://www.statista.com/statistics/1248657/clinical-drug-trials-by-key-therapeutic-area/
Share
